
AACR 2025: A topical BRAF-inhibiting gel may mitigate acneiform rash in patients receiving EGFR-targeted therapy for colorectal cancer
Patients with colorectal cancer who had acneiform rash and applied LUT014 gel, an investigational topical BRAF inhibitor,…